Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001209191-22-019808 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-17 | 2022-03-15 | CRBU | Fischesser Ryan | VP of Fin, Ctrl | M - OptEx | $3.40 | +2,274 | 113.2K | +2% | +$7,733 |
| DM | 2022-03-17 | 2022-03-15 | CRBU | Fischesser Ryan | VP of Fin, Ctrl | M - OptEx | $0.00 | -2,274 | 19.3K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | M | A | 1,136 | $2.69 | 112,106 | D | — | — | (F1) Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021. (F2) Includes 1,888 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2022 for $9.85 per share. |
| 2 | Common | Common Stock | 2022-03-15 | M | A | 1,138 | $4.11 | 113,244 | D | — | — | |
| 3 | Derivative | Option to purchase Common Stock | 2022-03-15 | M | D | 1,136 | $0.00 | 5,679 | D | $2.69 · — to 2029-03-18 | 1,136 Common Stock | (F1) Due to a rounding error, the exercise price for this stock option was inadvertently originally reported as $2.68 per share on the reporting person's Form 3 filed on July 23, 2021. (F3) 1/4th of the shares subject to this option vested on January 1, 2020 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2023, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. The vesting schedule for this option was inadvertently described incorrectly in the reporting person's Form 3 filed on July 23, 2021. |
| 4 | Derivative | Option to purchase Common Stock | 2022-03-15 | M | D | 1,138 | $0.00 | 19,314 | D | $4.11 · — to 2031-03-29 | 1,138 Common Stock | (F4) 1/4th of the shares subject to this option vested on January 1, 2022 and an additional 1/48th of the aggregate number of shares subject to the option have vested or will vest on the corresponding day of each month thereafter until the option is fully vested on January 1, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates. |